miRNAs differentially expressed during virus infection. (a) Overview of 45 miRNAs differentially expressed in mouse lung samples during SARS-CoV (MA15) or influenza virus (PR8) infection. Colors on the heat map indicate the log2 ratios of expression (representing normalized read counts) in virus-infected samples to expression in matched mock-infected samples. Red, upregulation; green, downregulation. The data in the eight columns under “small RNA NGS” represent log2 ratios of expression in virus-infected samples to expression in mock-infected samples as determined on the basis of small RNA transcriptome sequencing analysis. NGS, next-generation sequencing. The nine columns under “published microarray” represent log2 ratios determined on the basis of the microarray measurements of the corresponding miRNAs in lung samples from a previous study (3) in which mice were infected with the fully reconstructed 1918 pandemic (1918) or a nonlethal seasonal (Tx) influenza virus. The three columns under “1918/Tx” show the results of direct comparisons of miRNA expression in 1918-infected samples to expression in Tx-infected samples at 1, 3, and 5 days after infection; note that only changes of at least 1.5-fold are indicated. The log2 ratios of expression in infected samples to expression in mock-infected samples are shown separately under “1918” and “Tx,” where rows in grey indicate that the corresponding miRNAs were not probed by the miRNA microarray and rows in white indicate undetected miRNAs. The left sidebar shows the relative abundances of the corresponding miRNAs represented as the minimum average normalized read counts across all samples. (b) Patterns of changes in expression of selected miRNAs across a panel of virus infection samples measured by qPCR. Six miRNAs from panel a (indicated in boldface and italics) were selected; two, namely, miR-155 in macrophages (10) and miR-223 in neutrophils (11), are known to be related to immune cells. The other four miRNAs came from a small-scale screening performed using qPCR with a subset of randomly selected differentially expressed miRNAs in PWK/PhJ mouse embryonic fibroblasts (MEFs) infected with influenza virus (data not shown). Also, miR-27a* and miR-671-3p were not measured by previous microarray (see panel a). Colors on the heat map indicate the log2 ratios (the differences between medians of normalized Ct values of replicate samples) of expression in virus-infected samples to expression in matched mock-infected samples. Red, upregulation; green, downregulation. The “Lung + Flu” data contrast miRNA expression changes in lung samples from mice infected with highly pathogenic influenza virus (WT, VN1203) and with minimally pathogenic influenza virus (HA, VN1203 with a mutation in HA protein) at two time points: days 2 and 4 after infections. Similarly, the “Lung + SARS” data contrast miRNA expression changes in lung samples from mice infected with highly pathogenic SARS-CoV (MA, MA15) and minimally pathogenic SARS-CoV (Urb, Urbani). The “PWK MEFs + Flu” data represent temporal miRNA expression changes in samples from cultured PWK MEFs infected with the mouse-adapted A/PR/8/34 influenza virus across four time points after infection. A more detailed representation of individual replicate experiments is shown in Fig. S3. WT, wild type.